实验库 数据相关信息

题目:
Effect of imatinib on philadelphia chromosome positive acute lymphoblastic leukemia
ID:
状态:
发布时间Sept. 10, 2010 , 更新时间 June 10, 2011
物种:
Homo sapiens
摘要:
The Philadelphia chromosome (Ph) encodes the oncogenic BCR-ABL1 tyrosine kinase, which defines a subset of acute lymphoblastic leukemia (ALL) with a particularly unfavorable prognosis. In this study, the tyrosine kinase inhibitor imatinib was used for pharmacological inhibition of BCR-ABL1. Gene expression profiles of Ph+ ALL cell lines were analyzed in response to imatinib treatment. Four Ph+ ALL cell lines (BV-173, NALM-1, SUP-B15, and TOM1) were either treated with 10µM STI571 (Imatinib) for 16 hours or cultured in absence of STI571.
实验种类:
transcription profiling by array
样本量:
8
实验设计:
无设计数据
数据号:
E-GEOD-23743, GSE23743
数据状态:

无法自动分析,您可以尝试手动分析数据。

联系方式

山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。